1.A study on menarche and skeletal maturity among various malocclusion groups.
Kyung Ho KIM ; Hyoung Seon BAIK ; Eun Sue SON
Korean Journal of Orthodontics 1998;28(4):581-589
In order to correct a maxillofacial-skeletal disharmony successfully and achieve a favorable facial profile, orthodontic treatment must begin at pubertal growth spurt. Therefore predicting the pubertal growth pattern and evaluating the growth potential is very important For an orthodontist, estimating skeletal maturity in relation to one's personal growth spurt is essential and it must be considered into the treatment. The objective of this study was to find out whether there was a difference in menacheal age among different malocclusion groups and to evaluate the skeletal maturity at menarche. The subjects were 64 Class I malocclusion patients, 51 Class 1I patients and 38 Class III patients. Skeletal maturity was estimated from handwrist radiographs of these patients. Handwrist radiographs were taken between 3 months before and after the menarche. The results were as follows. 1. The mean chronologic age of menarche was 12.50+/-1.01 years. 2. For the Class I malocclusion group the mean age cf menarche was 12.36+/-1.04 years, for Class II 12.81+/-1,03 years and for Class III 12.32+/-0.82 years. According to these results Class II malocclusion patients started mensturation later than Class I and. Class III malocclusion patients. 3. No difference was found considering the skeletal maturity at menarche among the malocclusion groups. 4. The skeletal maturity index at menarche was SMI 7 for 45.10%, SMI 8 for 27.25%, SW 9 for 10.46%, SMI 6 for 7.84%, SMI 10 for 7.84% and SMI 5 for 1.31% patients. 5. Statistically there was a significant correlation between skeletal maturity estimated by handwrist radiographs and menacheal age( P<0.05, r-0.25430).
Female
;
Growth and Development
;
Humans
;
Malocclusion*
;
Menarche*
2.Delayed diagnosis of postintubation tracheal laceration in a patient who underwent septorhinoplasty including osteotomy: A case report
Hyo Jung SON ; Sue Jean MUN ; Jin Woo KOH ; Tae Woong KIM ; Hyun Su RI ; Hyae Jin KIM ; Gwi Eun YEO ; Dong Kyu LEE ; Yoon Ji CHOI
Anesthesia and Pain Medicine 2018;13(1):102-106
Iatrogenic postintubation tracheal injury is a rare but potentially fatal complication associated with anesthesia. However, as signs of tracheal injury including subcutaneous emphysema, pneumomediastinum, pneumothorax, and respiratory distress may also be related to surgical technique, diagnosis may be confused and treatment of tracheal injury can be delayed. We report a case of postintubation tracheal laceration, whose diagnosis was delayed because of symptoms were confused with subcutaneous emphysema after septorhinoplasty including osteotomy. As symptoms deteriorated in spite of conventional management, patient underwent evaluation to determine other causes and eventually postintubation tracheal injury was detected. Therefore, even if there is no problem during tracheal intubation, it is necessary to consider postintubation tracheal injury in patients with subcutaneous emphysema that worsens despite appropriate treatment after septorhinoplasty including osteotomy.
Anesthesia
;
Delayed Diagnosis
;
Diagnosis
;
Humans
;
Intubation
;
Intubation, Intratracheal
;
Lacerations
;
Mediastinal Emphysema
;
Osteotomy
;
Pneumothorax
;
Subcutaneous Emphysema
3.Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.
Jong Han YU ; Jong Won LEE ; Byung Ho SON ; Sung Won KIM ; Sue K PARK ; Min Hyuk LEE ; Lee Su KIM ; Woo Chul NOH ; Eun Kyu KIM ; Dae Sung YOON ; Jeeyeon LEE ; Jin Hyang JUNG ; Sang Seol JUNG ; Gyungyup GONG ; Sei Hyun AHN
Journal of Breast Cancer 2014;17(2):129-135
PURPOSE: Mutations in BRCA genes are the main cause of hereditary breast cancer in Korea. The aim of this study was to investigate the characteristics of breast cancers involving BRCA1 (BRCA1 group) and BRCA2 (BRCA2 group) mutations. METHODS: We retrospectively reviewed the medical records of patients with BRCA1 (BRCA1 group) or BRCA2 (BRCA2 group) mutation positive breast cancer from multiple centers and compared the data to that of the Korean Breast Cancer Society registry (registry group). RESULTS: The patients of the BRCA1 group were diagnosed at a younger age (median age, 37 years) and had tumors of higher histological (61.3% with histological grade 3) and nuclear (37.5% with nuclear grade 3) grade than those of the registry group. In addition, the frequency of ductal carcinoma in situ in the BRCA1 group was lower (3.7%) than in the registry group, and the BRCA1 group were more likely to be triple-negative breast cancer (61.3%). Patients in the BRCA2 group were also younger at diagnosis (mean age, 41 years) and were more likely to have involvement of the axillary node than the registry group (45.5% vs. 33.5%, p=0.002). The BRCA1 and BRCA2 groups did not show a correlation between tumor size and axillary node involvement. CONCLUSION: We report the characteristics of BRCA mutation positive breast cancer patients in the Korean population through multicenter data and nation-wide breast cancer registry study. However, BRCA-mutated breast cancers appear highly complex, and further research on their molecular basis is needed in Korea.
Breast Neoplasms*
;
Breast*
;
Carcinoma, Intraductal, Noninfiltrating
;
Diagnosis
;
Genes, BRCA1
;
Genes, BRCA2
;
Humans
;
Korea
;
Medical Records
;
Retrospective Studies
;
Triple Negative Breast Neoplasms
4.Prevalence of Primary Immunodeficiency in Korea.
Jung Woo RHIM ; Kyung Hyo KIM ; Dong Soo KIM ; Bong Seong KIM ; Jung Soo KIM ; Chang Hwi KIM ; Hwang Min KIM ; Hee Ju PARK ; Ki Soo PAI ; Byong Kwan SON ; Kyung Sue SHIN ; Moo Young OH ; Young Jong WOO ; Young YOO ; Kun Soo LEE ; Kyung Yil LEE ; Chong Guk LEE ; Joon Sung LEE ; Eun Hee CHUNG ; Eun Hwa CHOI ; Youn Soo HAHN ; Hyun Young PARK ; Joong Gon KIM
Journal of Korean Medical Science 2012;27(7):788-793
This study represents the first epidemiological study based on the national registry of primary immunodeficiencies (PID) in Korea. Patient data were collected from 23 major hospitals. A total of 152 patients with PID (under 19 yr of age), who were observed from 2001 to 2005, have been entered in this registry. The period prevalence of PID in Korea in 2005 is 11.25 per million children. The following frequencies were found: antibody deficiencies, 53.3% (n = 81), phagocytic disorders, 28.9% (n = 44); combined immunodeficiencies, 13.2% (n = 20); and T cell deficiencies, 4.6% (n = 7). Congenital agammaglobulinemia (n = 21) and selective IgA deficiency (n = 21) were the most frequently reported antibody deficiency. Other reported deficiencies were common variable immunodeficiencies (n = 16), X-linked agammaglobulinemia (n = 15), IgG subclass deficiency (n = 4). Phagocytic disorder was mostly chronic granulomatous disease. A small number of patients with Wiskott-Aldrich syndrome, hyper-IgE syndrome, and severe combined immunodeficiency were also registered. Overall, the most common first manifestation was pneumonia. This study provides data that permit a more accurate estimation PID patients in Korea.
Adolescent
;
Agammaglobulinemia/congenital/epidemiology
;
Age Distribution
;
Child
;
Child, Preschool
;
Common Variable Immunodeficiency/epidemiology
;
Female
;
Genetic Diseases, X-Linked/epidemiology
;
Humans
;
IgA Deficiency/epidemiology
;
IgG Deficiency/epidemiology
;
Immunologic Deficiency Syndromes/*epidemiology
;
Infant
;
Infant, Newborn
;
Job's Syndrome/epidemiology
;
Male
;
Prevalence
;
Questionnaires
;
Registries
;
Republic of Korea/epidemiology
;
Severe Combined Immunodeficiency/epidemiology
;
Sex Distribution
;
Wiskott-Aldrich Syndrome/epidemiology
;
Young Adult
5.The prevalence and risk factors of allergic rhinitis from a nationwide study of Korean elementary, middle, and high school students.
Yeongho KIM ; Ju Hee SEO ; Ji Won KWON ; Eun LEE ; Song I YANG ; Hyun Ju CHO ; Mina HA ; Eunae BURM ; Kee Jae LEE ; Hwan Cheol KIM ; Sinye LIM ; Hee Tae KANG ; Mia SON ; Soo Young KIM ; Hae Kwan CHEONG ; Yu Mi KIM ; Gyung Jae OH ; Joon SAKONG ; Chul Gab LEE ; Sue Jin KIM ; Yong Wook BEAK ; Soo Jong HONG
Allergy, Asthma & Respiratory Disease 2015;3(4):272-280
PURPOSE: We investigated the prevalence and risk factors of allergic rhinitis (AR), nationwide in random children and adolescents of Korea. METHODS: A modified International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire survey was done in 1,820 children from elementary, middle, and high school nationwide in Korea. The subjects were selected by the stratifying sampling method by school grade and five regions. Current AR was defined as having AR symptoms during the last 12 months with a history of physician-diagnosed AR. Skin prick tests for 18 common allergens were performed. RESULTS: The number of males was 945, and that of females was 875. The mean age of the patients was 12.61+/-3.40 years. The prevalence of current AR and atopic current AR were 29.0% and 18.7%, respectively. Risk factors for current AR were male (adjusted odds ratio [aOR], 1.486; 95% confidence interval [CI], 1.189-1.856), family history of paternal AR (aOR, 3.208; 95% CI, 2.460-4.182), family history of maternal AR (aOR, 3.138; 95% CI, 2.446-4.025), antibiotic use in infancy (aOR, 1.547; 95% CI, 1.228-1.949), mold exposure during infancy (aOR, 1.416; 95% CI, 1.103-1.819), mold exposure during the last 12 months (aOR, 1.285; 95% CI, 1.012-1.630), and sensitization on skin prick tests (aOR, 2.596; 95% CI, 2.055-3.279). Risk factors for atopic current AR were the same as those of current AR, whereas breast-milk feeding (aOR, 0.720; 95% CI, 0.530-0.976) was a protective factor. Sensitized allergens as risk factors for current AR were Dermatophagoides pteronyssinus, Dermatophagoides farina, ragweed, mugwort, oak, alder, birch, Japanese hop, cat, and dog. CONCLUSION: The prevalences of current AR and atopic current AR were 29.0% and 18.7%, respectively. Male, sex parental AR, antibiotic use in infancy, mold exposure during the last 12 months, mold exposure during infancy, and atopic sensitization were risk factors for current AR. Breast-milk feeding was a protective factor for atopic current AR. Aeroallergen sensitization was an important risk factor for AR.
Adolescent
;
Allergens
;
Alnus
;
Ambrosia
;
Animals
;
Artemisia
;
Asian Continental Ancestry Group
;
Asthma
;
Betula
;
Cats
;
Child
;
Dermatophagoides pteronyssinus
;
Dogs
;
Female
;
Fungi
;
Humans
;
Humulus
;
Hypersensitivity
;
Korea
;
Male
;
Odds Ratio
;
Parents
;
Prevalence*
;
Pyroglyphidae
;
Rhinitis*
;
Risk Factors*
;
Skin
6.The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report.
Sang Ah HAN ; Sue K PARK ; Sei Hyun AHN ; Byung Ho SON ; Min Hyuk LEE ; Doo Ho CHOI ; Dong Young NOH ; Wonshik HAN ; Eun Sook LEE ; Seo Kyung HAN ; Lee Su KIM ; Yongsik JUNG ; Ku Sang KIM ; Young Jin SUH ; Byung In MOON ; Seok Jin NAM ; Woo Chul NOH ; Jeong Eon LEE ; Sung Won KIM
Journal of Breast Cancer 2009;12(2):92-99
PURPOSE: To estimate the cumulative risk till each age (penetrance) of breast and ovarian cancers among female family members with BRCA1 and BRCA2 mutation. METHODS: Among the 61 BRCA1 mutation carriers in the 42 families and 47 BRCA2 mutation carriers in 31 families identified at 5 academic breast clinics, the probands were excluded to estimate the cumulative risk till each age of breast cancer in the Korean BRCA1 and BRCA2 carriers. Using Kaplan-Meier analyses, cumulative cancer risk estimates were determined. RESULTS: By the age 70, the female breast cancer risk for the BRCA1 and BRCA2 mutation carriers was 72.1% (95% confidence interval [CI]=59.5% to 84.8%) and 66.3% (95% CI=41.2% to 91.5%), respectively, and the ovarian cancer risk was 24.6% (95% CI=0% to 50.3%) and 11.1% (95% CI=0% to 31.6%), respectively. The contralateral breast cancer risk at 5 years after primary breast cancer was estimated as 16.2% (95% CI=9.3% to 23.1%) for the 52 breast cancer patients with the BRCA1 mutation and 17.3% (95% CI=9.7% to 24.0%) for the 35 breast cancer patients with the BRCA2 mutation. CONCLUSION: The penetrance of BRCA mutations in Korea is largely consistent with the previous studies on Western populations. However, the small number of the cases, the high proportions of probands in the study subjects, the short term follow-up, and large confidence intervals are the limitations of the current study. The Korean Hereditary Breast Cancer Study (KOHBRA Study) may definitely answer this question.
Breast
;
Breast Neoplasms
;
Female
;
Follow-Up Studies
;
Humans
;
Korea
;
Ovarian Neoplasms
;
Penetrance